2.615
1.88%
-0.045
전일 마감가:
$2.66
열려 있는:
$2.65
하루 거래량:
75,768
Relative Volume:
0.10
시가총액:
$75.80M
수익:
-
순이익/손실:
$-75.52M
주가수익비율:
-1.0058
EPS:
-2.6
순현금흐름:
$-56.92M
1주 성능:
+1.95%
1개월 성능:
+11.54%
6개월 성능:
-86.81%
1년 성능:
-82.00%
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
명칭
Aerovate Therapeutics Inc
전화
617-443-2400
주소
930 WINTER STREET, WALTHAM
AVTE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AVTE | 2.61 | 75.80M | 0 | -75.52M | -56.92M | -2.60 |
VRTX | 450.36 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.27 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 591.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.36 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-03-01 | 개시 | Guggenheim | Buy |
2022-12-06 | 업그레이드 | BTIG Research | Neutral → Buy |
2022-09-19 | 재개 | Wedbush | Outperform |
2022-08-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
2022-02-11 | 개시 | BTIG Research | Buy |
2021-07-26 | 개시 | Cowen | Outperform |
2021-07-26 | 개시 | Evercore ISI | Outperform |
2021-07-26 | 개시 | Jefferies | Buy |
2021-07-26 | 개시 | Wedbush | Outperform |
모두보기
Aerovate Therapeutics Inc 주식(AVTE)의 최신 뉴스
GSA Capital Partners LLP Has $865,000 Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declines By 17.3% - MarketBeat
Wedbush Research Analysts Raise Earnings Estimates for AVTE - Defense World
What is Wedbush's Forecast for AVTE FY2024 Earnings? - MarketBeat
Aerovate Therapeutics Reports Q3 Loss Amid Strategic Shift - TipRanks
Finansavisen - Finansavisen
Jade Biosciences’ Merger with Aerovate Therapeutics - Global Legal Chronicle
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire
Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World
How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve
SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow
Form 425 Aerovate Therapeutics, Filed by: Aerovate Therapeutics, Inc. - StreetInsider.com
Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Jade Biosciences and Aerovate announce merger deal - Investing.com
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch
Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Aerovate climbs on all-stock merger deal with Jade - MSN
Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat
Aerovate Therapeutics regains Nasdaq compliance - Investing.com India
Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada
Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail
Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat
Aerovate Therapeutics announces board member resignation - Investing.com India
Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK
XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat
Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex
AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes
Why AeroVironment Shares Are Flying Higher Today - sharewise
Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World
AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga
Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks
Aerovate Therapeutics Inc (AVTE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):